Cancer and renal insufficiency results of the BIRMA study

British Journal of Cancer

Volumn 103, Issue 12, 2010, Pages 1815-1821

  Janus, N ^a   Launay Vacher, V ^a   Byloos, E ^b   MacHiels, J P ^c   Duck, L ^d   Kerger, J ^e   Wynendaele, W ^f   Canon, J L ^g   Lybaert, W ^h   Nortier, J ⁱ   Deray, G ^a   Wildiers, H ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d Clinique Saint Pierre of Ottignies   (Belgium)

^e UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^f IMELDA HOSPITAL   (Belgium)

^g Department of Medical Oncology   (Belgium)

^h AZ Nikolaas   (Belgium)

ⁱ ERASME HOSPITAL   (Belgium)

Author keywords

anticancer drugs; dose adjustment; renal insufficiency

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; CREATININE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; EXEMESTANE; FLUOROURACIL; GEMCITABINE; IBANDRONIC ACID; IRINOTECAN; LETROZOLE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PAMIDRONIC ACID; TAMOXIFEN; TEMOZOLOMIDE; TRASTUZUMAB; ZOLEDRONIC ACID;

ADULT; AGE; ANEMIA; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG OVERDOSE; FEMALE; GLOMERULUS FILTRATION RATE; GYNECOLOGIC CANCER; HEMOGLOBINEMIA; HUMAN; KIDNEY FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEOPLASM; NEPHROTOXICITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; SEX; VISCERAL METASTASIS;

ADULT; AGED; ANEMIA; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; RENAL INSUFFICIENCY;

EID: 78650018615     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605979     Document Type: Article

References (22)

1. Aapro MS, Link H (2008) September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents. Oncologist 13(Suppl 3): 33-36
2. Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, Pasko DA, Smoyer WE (2007) Drug Prescribing in Renal Failure Dosing Guidelines for Adultes and Children, 5th edn. American College of Physicians: Philadelphia
3. Barraclough LH, Field C, Wieringa G, Swindell R, Livsey JE, Davidson SE (2008) Estimation of renal function-what is appropriate in cancer patients? Clin Oncol (R Coll Radiol) 20: 721-726
4. Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME, Wiltshaw E (1989) Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J Clin Oncol 7: 1748-1756
5. Cengiz K (2002) Increased incidence of neoplasia in chronic renal failure (20-year experience). Int Urol Nephrol 33: 121-126
6. Chatelut E, Rostaing L, Gualano V, Vissac T, De Forni M, Ton-That H, Suc JM, Houin G, Canal P (1994) Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysisdependent renal insufficiency. Nephron 66: 157-161
7. Dogan E, Izmirli M, Ceylan K, Erkoc R, Sayarlioglu H, Begenik H, Alici S (2005) Incidence of renal insufficiency in cancer patients. Adv Ther 22: 357-362
8. Harper P, Littlewood T (2005) Anaemia of cancer: Impact on patient fatigue and long-term outcome. Oncology 69(Suppl 2): 2-7
9. Holweger K, Lipp HP, Dietz K, Hartmann JT, Bokemeyer C (2008) Novel algorithm for more accurate calculation of renal function in adults with cancer. Ann Pharmacother 42: 1749-1757
10. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY (1998) Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32: 992-999
11. Kleber M, Cybulla M, Bauchmuller K, Ihorst G, Koch B, Engelhardt M (2007) Monitoring of renal function in cancer patients: An ongoing challenge for clinical practice. Ann Oncol 18: 950-958
12. Launay-Vacher V, Isnard-Bagnis C, Janus N, Karie S, Deray G (2008) Chemotherapy and renal toxicity. Bull Cancer 95 FMC Onco: F96-F103
13. Launay-Vacher V, Izzedine H, Rey JB, Rixe O, Chapalain S, Nourdine S, Paci A, Bourget P, Deray G (2004) Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit 10: CR209-CR212
14. Launay-Vacher V, Karie S, Deray G (2009) GPR Anticancéreux. 4th edn. Méditions International: Paris
15. Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G (2007) Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: The renal insufficiency and anticancer medications (IRMA) study. Cancer 110: 1376-1384
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470
17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100
18. Lichtman SM, Wildiers H, Launay-Vacher V, Steer C, Chatelut E, Aapro M (2007) International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency. Eur J Cancer 43: 14-34 (Pubitemid 46070218)
19. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67: 706-713 (Pubitemid 40139864)
20. NKF (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266
21. Schwartz RN (2007) Anemia in patients with cancer: Incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm 64: S5-S13; quiz S28-30
22. Sutherland GA, Glass J, Gabriel R (1977) Increased incidence of malignancy in chronic renal failure. Nephron 18: 182-184